APP to launch Imipenem and Clilastatin, Meropenen in US
The company will begin the shipment of Meropenem for Injection in 500mg and 1gm single dose vials from 13 February 2012. The Imipenem and Cilastatin for Injection in
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.